...Jiawei Zhang; Dandan Li; Rui Zhang; Peng Gao; Rongxue Peng; Jinming Li The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize...

... BY) . biomarkers cancer cannibalism cell-in-cell entosis p53 Cell-in-cell (CIC) is a term used in histopathology to describe a phenomenon in which one whole cell can be detected inside another cell [ 1 , 2 ]. The inside cell is often rounded up, usually alive, and resides inside a large vacuole...

... are able of up-taking proteins and genetic material present in the bloodstream. Platelets are like ‘sentinels’ of the disease state. The evaluation of proteomics and transcriptomics signature of platelets and platelet-derived microparticles could represent a new strategy for the development of biomarkers...

... functions in normal physiology, it is unsurprising that EVs are involved in multiple pathologies including cardiac disease, neurological diseases and cancer. biomarkers exosome extracellular vesicle microvesicle RNA translation Interest in extracellular vesicles (EVs) has grown...

... with the disease. There are currently no known biomarkers for the disease, largely due to the lack of knowledge surrounding the eitopathogenesis of CFS/ME. Numerous studies have been conducted in an attempt to identify potential biomarkers for the disease. This mini-review offers a brief summary of current...

...-coding genes were thought to be casual to many human ailments. However, the potency in which lncRNAs can modulate gene expression in a plethora of cellular processes sets a precedent for lncRNAs to play a significant role in the etiology of human disease. biomarkers disease gene expression...

... 2017 1 6 2017 © 2017 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society 2017 biomarkers cytokines exercise oncology immune response physical training physiology Over the past 25 years, the field of clinical oncology has experienced...

... for the development of PD-related biomarkers. Correspondence: Jean-Mare Taymans ( jean-marc.taymans@inserm.fr ) or Marie-Christine Chartier-Harlin ( marie-christine.chartier-harlin@inserm.fr ) 22 9 2016 25 11 2016 2 12 2016 © 2017 The Author(s); published by Portland Press Limited on behalf...